Journal of Hepatology
Volume 53, Issue 2 , Pages 283-290, August 2010

Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis☆

  • Florence Wong

      Affiliations

    • Department of Medicine, University of Toronto, Canada
    • Corresponding Author InformationCorresponding author. Address: 9th floor, North Wing, Room 983, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada M5G2C4. Tel.: +1 416 340 3834; fax: +1 416 340 5019.
    • ,
  • Pere Gines

      Affiliations

    • Hospital Clinic, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Catalunya, Spain
    • ,
  • Hugh Watson

      Affiliations

    • Internal Medicine, Clinical Development, Sanofi-Aventis R&D, Chilly-Mazarin, France
    • ,
  • Yves Horsmans

      Affiliations

    • Saint-Luc University Hospital, Brussels, Belgium
    • ,
  • Paolo Angeli

      Affiliations

    • University of Padova, Italy
    • ,
  • Paul Gow

      Affiliations

    • Austin Hospital, University of Melbourne, Australia
    • ,
  • Pascal Minini

      Affiliations

    • Internal Medicine, Clinical Development, Sanofi-Aventis R&D, Chilly-Mazarin, France
    • ,
  • Mauro Bernardi

      Affiliations

    • Department of Internal Medicine, University of Bologna, Italy

Received 17 January 2010; received in revised form 22 February 2010; accepted 23 February 2010. published online 31 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The study was registered on a public clinical trial registry website, www.ClinicalTrials.org, number NCT 00501384.

PII: S0168-8278(10)00381-8

doi:10.1016/j.jhep.2010.02.036

Refers to article:

  • May vaptans contribute to the treatment of refractory ascites? , 07 May 2010

    Francesco Salerno, Massimo Cazzaniga, Silvia Accordino
    Journal of Hepatology August 2010 (Vol. 53, Issue 2, Pages 225-227)

Journal of Hepatology
Volume 53, Issue 2 , Pages 283-290, August 2010

Article Tools

* Image Usage & Resolution